VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EOCN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EOCNEocene Ltd.
$2.46$3M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEOCNCash Flow

Eocene Ltd. (EOCN) Cash Flow Statement

14Y historyFree accessUpdated daily

Operating cash flow was negative in nine of ten quarters and free cash flow was negative throughout with zero CapEx, implying sustained cash burn that investors should monitor against the $3.0M cash balance and the $3.2M net acquisition outflow in 2026Q2.

Income StatementBalance SheetCash FlowRatios

EOCN Cash Flow Statement

Annual statement

EOCN Cash Flow Statement

Eocene Ltd. (EOCN) cash flow statement — 14-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Cash from Operations-8.54M-6.32M-5.88M-6.14M-18.5M-32.89M-26.29M-14.94M-9.02M-12.07M-12.13M-8.47M-9.24M-2.52M-3.08M
Operating CF Margin %---------442.74%-1112.17%-2597.22%----
Operating CF Growth %-265.7%-7.4%4.19%66.83%43.75%-25.13%-75.99%-65.54%25.23%0.51%-43.13%8.3%-266.13%18.03%-
Net Income-11.34M-10.31M-7.52M-6.91M-17.87M-32.47M-28.77M-20.46M-9.86M-12.3M-16.95M-10.62M-9.1M-17.48M-3.15M
Depreciation & Amortization0083K31K35K42K39K35K387K239K169K50K9K4K5K
Stock-Based Compensation501K546K531K892K1.3M1.89M2.07M2.23M1.78M1.39M1.63M970K601K10.85M208K
Deferred Taxes0000084K-437K-114K12K164K-1.4M-920K-601K0-208K
Other Non-Cash Items2.54M2.54M1.75M-280K485K13K-285K-63K-144K-167K1.67M1.06M601K2.89M208K
Working Capital Changes-238K912K-728K132K-2.45M-2.45M1.1M3.44M-1.21M-1.4M2.75M986K-748K1.22M-143K
Change in Receivables108K240K-192K345K300K-313K15K-609K-63K129K95K-214K-149K-2K-11K
Change in Inventory0000-300K313K-15K609K-142K671K81K39K-91K228K-103K
Change in Payables520K695K-571K-681K-2.31M-2.17M1.05M4.18M-462K-846K863K1.38M-480K954K-89K
Cash from Investing3.82M-3.38M-1.11M800K17.56M11.46M16.54M6.68M-60.02M6.44M6.34M-11.11M-9.02M3K-32K
Capital Expenditures0000-4K-11K-44K-12K-90K-21K-17K-159K-770K-13K-32K
CapEx % of Revenue--------4.42%1.94%3.64%----
Acquisitions-3.18M00-1.5M-17.57K0-24.94M21.8M6.08M013K-6M8.25M00
Investments---------------
Other Investing00-250K017.57K-1K24.94M-21.8M-6.08M9K13K6M-6M16K0
Cash from Financing2.68M9.03M8.79M6.18M70K17.37M768K143K80.18M15.55M4.73M041.86M1.94M3.68M
Debt Issued (Net)00000000000001.82M20K
Equity Issued (Net)2.68M9.03M8.79M6.18M70K17.37M707K079.15M15.02M4.48M041.86M120K0
Dividends Paid000000000000000
Share Repurchases000000000000000
Other Financing00000061K143K1.03M530K255K0003.66M
Net Change in Cash-2.04M-664K1.79M848K-868K-4.06M-8.98M-8.12M11.14M9.92M-1.06M-19.58M23.6M-581K572K
Free Cash Flow-8.54M-6.32M-5.88M-6.14M-18.5M-32.9M-26.33M-14.95M-9.11M-12.09M-12.15M-8.63M-10.01M-2.54M-3.11M
FCF Margin %---------447.15%-1114.1%-2600.86%----
FCF Growth %-56.24%-7.4%4.19%66.84%43.76%-24.96%-76.14%-64.04%24.61%0.48%-40.69%13.76%-294.6%18.45%-
FCF per Share-8.97-11.72-50.54-212.73-88.32-160.52-148.48-84.96-60.29-116.16-128.14-11.67-14.55-3.56-9.21
FCF Conversion (FCF/Net Income)0.75x0.61x0.78x0.89x1.04x1.01x0.91x0.73x0.92x0.98x0.72x0.80x1.02x0.14x0.98x
Interest Paid00000000865K0382K0000
Taxes Paid0000000075K0106K01K00

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Sustained operating cash burn

Losses Paired With Persistent Cash Burn

Based on EOCN's reported quarterly figures, operating cash flow was negative in nine of the ten quarters from 2024Q1 through 2026Q2, with the OCF-to-net-income ratio ranging widely from 0.40 to 1.44 and offering little evidence of earnings quality beyond the losses themselves.

Because net income is negative in every period, the OCF/NI ratios are mechanically positive but do not indicate healthy conversion; they simply reflect both measures being negative. The more meaningful observation is that operating cash outflows are of similar magnitude to reported losses, suggesting that non-cash charges such as stock-based compensation, which is modest at roughly $100K to $240K per quarter, explain only a small share of the gap. Investors should monitor whether the cash burn tracks R&D spending, which the prior income statement analysis identified as the dominant cost line.

Free Cash Flow Negative Without Revenue Base

As reported in EOCN's quarterly cash flow data, free cash flow was negative across all ten quarters, with no revenue recorded to compute a free cash flow margin and CapEx remaining at zero throughout the period.

The absence of any revenue denominator means FCF margin analysis is unavailable, and the cash flow profile reflects a pre-commercial operating structure rather than a business generating cash at scale. Reported free cash flow of roughly -$1.0M to -$2.5M per quarter is consistent with an entity funding development activity from its existing resources. This trajectory suggests the company's cash requirements are driven by operating spending rather than investment in productive assets.

Zero Capital Spending Signals Asset-Light Model

According to reported figures, EOCN recorded zero capital expenditure across all ten quarters, and with no depreciation and amortization of note beyond minor amounts, the company does not appear to be building a physical asset base.

The absence of CapEx is consistent with a development-stage biotech profile in which spending is concentrated in research rather than facilities or equipment. This reduces the risk of unrecovered fixed-asset investment but also means the company has not yet built capacity that would support future commercialization. Investors should note that the cash requirement sits entirely in operating expenses rather than capital investment.

No Shareholder Returns Amid Acquisition Activity

Based on EOCN's reported figures, dividends and share buybacks were zero across the period, while a single reported net acquisition outflow of roughly $3.2M in 2026Q2 stands out against otherwise minimal investing activity.

The absence of dividends and repurchases is expected for a loss-making company whose cash is being consumed by operations, so capital is effectively not being returned to shareholders. The 2026Q2 acquisition outflow is the single investing event of note and warrants further investigation into its purpose and strategic rationale, since it is large relative to the company's quarterly operating burn. Without disclosure of the acquired asset, its contribution to future cash generation cannot be assessed from the supplied data.

Cumulative Losses Raise Funding Questions

Based on reported quarterly figures, cumulative net losses across the ten periods exceed $20M while operating cash outflows have been sustained, raising questions about how long current resources can support operations without additional financing.

The reported cash flow data does not disclose the company's cash balance or financing arrangements, so runway cannot be quantified directly from the supplied information. The pattern of recurring operating outflows, combined with the acquisition outflow in the most recent quarter, suggests the balance sheet may be under increasing pressure, though this remains an inference that should be verified against the full balance sheet. Investors should monitor future equity issuance or dilution, which the earnings-per-share volatility noted in the income statement analysis may already partly reflect.

EOCN — Frequently Asked Questions

Quick answers to the most common questions about buying EOCN stock.

How much cash does Eocene Ltd. (EOCN) generate from operations?

Eocene Ltd. (EOCN) generated $-6.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Eocene Ltd.'s free cash flow?

Eocene Ltd. (EOCN) reported negative free cash flow of $6.3M in 2025, indicating capital requirements exceeded cash from operations.

What is Eocene Ltd.'s capital expenditure (CapEx)?

Eocene Ltd. (EOCN) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.